SCHEMBL17293159

SCHEMBL17293159

CCCCOC(=O)N1CCOCC1C(=O)CC(=O)OC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35
GBA2 Q9HCG7 1/20 0.35
CTSK P43235 2/20 0.35
USP2 O75604 1/20 0.35
CTSL P07711 2/20 0.33
CTSB P07858 2/20 0.33
TSHR P16473 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
SPHK1 Q9NYA1 1/20 0.32
P2RY12 Q9H244 2/20 0.32
RECQL P46063 1/20 0.32
ALDH1A1 P00352 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
MIF P14174 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17292975 0.86 SMN1; SMN2 (0.44) SMN1; SMN2LMNANPC1USP2MEN1
SCHEMBL17293151 0.86 SMN1; SMN2 (0.44) SMN1; SMN2LMNANPC1USP2MEN1
SCHEMBL31379341 0.81 SMN1; SMN2 (0.40) SMN1; SMN2LMNAPOLBRAB9AUSP2
SCHEMBL31379382 0.81 SMN1; SMN2 (0.40) SMN1; SMN2LMNAPOLBRAB9AUSP2
SCHEMBL17293189 0.80 SMN1; SMN2 (0.52) SMN1; SMN2LMNAPOLBNPC1MAPT
SCHEMBL3712797 0.80 SMN1; SMN2 (0.55) SMN1; SMN2LMNAPOLBNPC1MAPT
SCHEMBL12870626 0.78 SMN1; SMN2 (0.54) SMN1; SMN2LMNAPOLBNPC1MAPT
SCHEMBL16409131 0.76 SMN1; SMN2 (0.46) SMN1; SMN2POLBNPC1USP2TSHR
SCHEMBL13135766 0.74 LMNA (0.49) SMN1; SMN2LMNAPOLBNPC1MAPT
SCHEMBL9596202 0.74 GBA2 (0.32) SMN1; SMN2LMNAPOLBGBA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3149001-A1 NOVEL PYRAZOLO PYRIMIDINE DERIVATIVES AND THEIR USE AS MALT1 INHIBITORS Novartis AG (CH) 2017-04-05 EP disclosed
WO-2015181747-A1 NOVEL PYRAZOLO PYRIMIDINE DERIVATIVES AND THEIR USE AS MALT1 INHIBITORS NOVARTIS AG (CH) 2015-12-03 WO disclosed